Today RS Oncology celebrates World Ovarian Cancer Day. We are hard at work with our partner, Azierta Foundation, to bring innovative treatment options for ovarian cancer patients worldwide.
RS Oncology, LLC, announces UK Medicines and Healthcare Regulatory Agency’s clinical trial acceptance of new drug, RSO-021, for treatment of Pleural Effusion and Mesothelioma Cambridge, MA, October 1,
